Guerbet is a healthcare company focused on medical imaging, with a history spanning 90 years. As a pioneer in contrast media, it is the only pharmaceutical group dedicated exclusively to this field. Guerbet operates in nearly 80 countries through a network of subsidiaries and distributors, providing a wide array of products for various imaging modalities, including CT scans, magnetic resonance imaging (MRI), ultrasound, and nuclear medicine. The company’s portfolio includes well-known brands such as Xenetix, Optiray, Dotarem, and Telebrix, among others. Additionally, Guerbet offers injectors and related medical devices aimed at enhancing patient diagnosis, prognosis, and overall quality of life.
Senior Vice President and Head of Interventional Business Unit
3 past transactions
Accurate Medical Therapeutics
Acquisition in 2018
Accurate Medical Therapeutics is develops embolization microcatheter for the interventional radiology and interventional oncology markets.
Mallinckrodt - CMDS business
Acquisition in 2015
Mallinckrodt - CMDS business contrast media and delivery systems
Medex Biomedical
Acquisition in 2004
Medex Biomedical is a manufacturer of injection systems and medical devices headquartered in Saint Priest, France. The company specializes in producing injectors designed for computed tomography (CT) and angiography examinations. Additionally, Medex offers a wide array of disposables tailored for CT and angiography procedures, along with a selected range of products suitable for magnetic resonance imaging (MRI).
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.